Accès gratuit
Numéro
Med Sci (Paris)
Volume 26, Numéro 11, Novembre 2010
Page(s) 976 - 980
Section Resistance aux antibiotiques : un enjeu international
DOI https://doi.org/10.1051/medsci/20102611976
Publié en ligne 15 novembre 2010
  1. British Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. British Medical Journal 1948 ; 2 : 769-83.
  2. World Health Organisation. Anti-tuberculosis drug resistance in the world : fourth global report. WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance 2008, Genève, 142.
  3. European Center for Disease Prevention and Control, WHO Regional Office for Europe : Tuberculosis surveillance in Europe 2008, 2010, Stockholm.
  4. Khuê PM, Truffot-Pernot C, Texier-Maugein J, et al. A 10-year prospective surveillance of mycobacterium tuberculosis drug resistance in France 1995-2004. Eur Respir J 2007 ; 30 : 937-44.
  5. World Health Organisation. Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response 2010, Genève, 71.
  6. Chan ED, Laurel V, Strand MJ, et al. Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 2004 ; 169 : 1103-9.
  7. Flament-Saillour M, Robert J, Jarlier V, Grosset J. Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study. Am J Respir Crit Care Med 1999 ; 160 : 587-93.
  8. Uffredi ML, Truffot-Pernot C, Dautzenberg B, et al. An intervention programme for the management of multidrug-resistant tuberculosis in France. Int J Antimicrob Agents 2007 ; 29 : 434-9.
  9. Center for Disease Control and Prevention. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force. MMWR Recomm Rep 2009 ; 58 : 1-43.
  10. Center for Disease Control and Prevention. Emergence of mycobacterium tuberculosis with extensive resistance to second-line drugs-worldwide, 2000- 2004. MMWR Morb Mortal Wkly Rep 2006 ; 55 : 301-5.
  11. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006 ; 368 : 1575-80.
  12. Kliiman K, Altraja A. Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB. Eur Respir J 2009 ; 33 : 1085-94.
  13. Veziris N, Martin C, Brossier F, et al. Treatment failure in a case of extensively drug-resistant tuberculosis associated with selection of a GyrB mutant causing fluoroquinolone resistance. Eur J Clin Microbiol Infect Dis 2007 : 26 : 423-5.
  14. Diacon AH, Pym A, Grobusch M, et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med 2009 ; 360 : 2397-405.
  15. Ibrahim M, Truffot-Pernot C, Andries K, et al. Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis. Am J Respir Crit Care Med 2009 ; 180 : 553-7.
  16. Escudero E, Peña JM, Alvarez-Sala R, et al. Multidrug-resistant tuberculosis without HIV infection: success with individualised therapy. Int J Tuberc Lung Db 2006 ; 10 : 409-14.
  17. Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance. Jama 1993 ; 270 : 65-8.
  18. Brossier F, Veziris N, Jarlier V, Sougakoff W. Performance of MTBDR plus for detecting high/low levels of Mycobacterium tuberculosis resistance to isoniazid. Int J Tuberc Lung Dis 2009 ; 13 : 260-5.
  19. Frieden TR, Sherman LF, Maw KL, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. Jama 1996 ; 276 : 1229-35.
  20. World Health Organisation. Guidelines for the programmatic management of drug-resistant tuberculosis 2008, Genève.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.